Default Category
-
Oral Insulin: Breakthrough Innovation at Biocon
Nita Sachan; Prasad Kaipa; Anand Nandkumar; Charles DhanarajCase IVEY-9B11M065-EEntrepreneurship, Service and Operations Management, StrategyThis case deals with the innovation challenges of a medium-sized firm (under $1 billion) in an emerging economy (India), particularly the challenges of product development and commercialization. The management has to decide how to proceed with a promising novel formula for oral insulin — promising both in terms of financial returns as well as social impact. The company has spent several years of research and development in getting the drug throug...Starting at €8.20
-
Embrace (B): Opportunity Assessment
Mridula Anand; Anand Nandkumar; Charles DhanarajCase IVEY-9B13M005-EEntrepreneurship, StrategyAWARD WINNING CASE - Indian Management Issues and Opportunities Award, 2013 European Foundation for Management Development (EFMD) Case Writing Competition. Part B of a four-part series, which also includes 9B13M004, 9B13M006 and 9B13M007.Starting at €5.74
-
Embrace (C): Competing with Incumbents
Mridula Anand; Anand Nandkumar; Charles DhanarajCase IVEY-9B13M006-EEntrepreneurship, StrategyAWARD WINNING CASE - Indian Management Issues and Opportunities Award, 2013 European Foundation for Management Development (EFMD) Case Writing Competition. Part C of a four-part series, which also includes 9B13M004, 9B13M005 and 9B13M007.Starting at €5.74
-
Enpara.com: Digital Bank at a Crossroad
Gupta, Sunil; Kuzucu, ErenCase HBS-518030-EMarketingIn March 2017, Elsa Pekmez Atan (MBA 2004), was wondering about the future of Enpara.com, a digital-only banking platform of QNB Finansbank. Since its launch in October 2012, Enpara had been successful in attracting over 600,000 customers by appealing to digital savvy, middle-class customers that QNB Finansbank was lacking for a long time. By the end of 2016, it accounted 16% of QNB Finansbank's deposits. With the support of the top management, A...Starting at €8.20
-
Actera Group: Investing in Mars Cinema Group (B)
Ivashina, Victoria; Kuzucu, ErenCase HBS-218021-EFinanceIn summer of 2010, Murat avu o lu (HBS MBA 1994) led private equity firm Actera Group's investment in Mars Cinema Group (Mars), the leading movie exhibitor in Turkey. Immediately after acquiring Mars and merging it with the second larger player in the market, AFM, avu o lu focused on institutionalizing and implementing value creation work streams in Mars. While transforming an entrepreneurial company into an institutionalized firm, avu ...Starting at €5.74
-
Darby's Investment in Sirma: Professionalizing an Entrepreneurial Firm
Srinivasan, Suraj; Kuzucu, ErenCase HBS-117033-EAccounting and ControlIn March 2010, Burak Dalg n (HBS MBA 2004) led private equity firm Darby's investment in S rma, a local Turkish water and beverage company. S rma was owned and managed by members of two Turkish business families. The existing management, while being highly entrepreneurial, had paid less attention to managing the company in a professional manner, leading to a highly leveraged balance sheet and a significant need for financing. After the investm...Starting at €8.20
-
Fetchr: A New Way of Last Mile Delivery
Narayanan, V.G.; Kuzucu, ErenCase HBS-119018-EAccounting and ControlBy mid-2016, five years of aggressive growth had transformed Fetchr from a small logistics startup to a 1,000-employee, full-fledged last-mile delivery company operating across four countries in the Middle East and North Africa (MENA). Already beneficiaries of the largest Series A round to the Middle East from an American firm, CEO Idriss Al Rifai and the Fetchr team had ambitions of raising another $40 million in Series B and deliberated continu...Starting at €8.20
-
Centre for Cellular and Molecular Biology: The Commercialization Challenge
Nita Sachan; Prasad Vemuri; Anand Nandkumar; Charles DhanarajCase IVEY-9B11M064-ECorporate Governance, StrategyThis case deals with the commercialization challenges that a premier research institute in an emerging economy faces despite conducting cutting-edge research. The case is set in 2009 in Hyderabad, India, soon after the appointment of CCMB’s new director, Dr. Mohan Rao. Rao has to decide how to proceed with incentivizing the scientists to find potential applications for their research when most scientists are merely interested in doing basic resea...Starting at €8.20
-
Novartis in India: Innovation versus Affordability
Anand Nandkumar; Charles Dhanaraj; Mridula AnandCase IVEY-9B12M111-EStrategyThis case presents complex managerial challenges that stem from the institutional context in emerging markets, particularly in relation to the intellectual property regime and its impact on business strategy. The case centres around a multinational pharmaceutical firm, Novartis International AG (Novartis), that is waiting on a major court decision regarding patent policy as it pertains to one of the firm’s products. The case takes students throug...Starting at €8.20
-
Embrace (D): Building the Business Model
Mridula Anand; Anand Nandkumar; Charles DhanarajCase IVEY-9B13M007-EEntrepreneurship, StrategyAWARD WINNING CASE - Indian Management Issues and Opportunities Award, 2013 European Foundation for Management Development (EFMD) Case Writing Competition. Part D of a four-part series, which also includes 9B13M004, 9B13M005 and 9B13M006.Starting at €5.74